To define the potential phenotypes displayed by SORBS2-depleted cells that could enhance metastatic activity in vitro, we assessed the ability of SORBS2-knocked down ovarian cancer cells to migrate through Transwell chamber. Here, SORBS2 is linked to ovarian cancer.